Reports and Data

Biosimilars Market by Product Analysis Is Projected to Be Around USD 56.76 Billion by 2027 : Amgen, Biocon, Celltrion, Dr. Reddy's Laboratories, Etc.

A recent study on the Biosimilars market closely examines the performance of the major market vendors operating in the Biosimilars market for the forecast period 2020 to 2027.


New York, NY -- (SBWIRE) -- 10/16/2020 -- Global Biosimilars Market Research Report 2020 (Covers COVID-19 Impact Analysis)

Reports and Data offers an updated and up-to-the-minute study on the Global Biosimilars Market and contains estimations of market size, revenue, production and consumption, CAGR, gross margin, price analysis, and other key elements. The report also offers a comprehensive study about the current and emerging trends observed in the market, along with an emphasis on the key driving and restraining factors. The report further sheds light on the micro and macro-economic aspects that are anticipated to shape the demand of the Biosimilars industry. Moreover, it also covers the competitive landscape, including the profiles and business overview of the key companies and SWOT analysis.

The report is furnished with the impact of the current COVID-19 pandemic. The pandemic is rearranging every aspect of the market from the global economic scenario to product demands and supply chains. The report assesses the hardest-hit sectors of the industry to offer a better understanding of the changes in the Biosimilars market. The report is updated with the initial and future assessment of the impact of the COVID-19 pandemic on the Global Biosimilars Market.

The Global Biosimilars Market is projected to grow at a CAGR of 30.5% from USD 6.71 billion in 2019 to USD 56.76 Billion in 2027.

Get a Sample of the Report @

The report focuses on the Biosimilars market volume at a global and regional level, along with a special focus on the company level. The report represents an overall Biosimilars market size through a thorough analysis of the historical data and future prospects.

Regional analysis provided in the report covers the key regions of North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Additionally, the report offers a country-wise analysis of the Biosimilars industry with respect to the import/export analysis, production and consumption pattern, supply and demand ratio, revenue share, market share and size, and other key aspects.

The competitive landscape of the Biosimilars market is explored with regards to the production capacity, revenue and market share, product portfolio, strategic business decisions such as M&A, joint ventures, collaborations, product launches, and brand promotion, among others, for each manufacturer operating in the Biosimilars market.

Major Manufacturers Profiled in the Report:

Amgen, Biocon, Celltrion, Dr. Reddy's Laboratories, Mylan, Pfizer, Samsung Biologics, Sandoz, Stada Arzneimittel, and Teva Pahrmaceutical

Market Segmentation based on Key Geographical Regions:

North America (U.S.A., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Get Discount on the Report @

Type (Revenue, USD Million; 2016–2026)
1. Recombinant Non-glycosylated Proteins
a. Insulin
b. Recombinant Human Growth Hormone
c. Granulocyte Colony-stimulating Factor
i. Filgrastim
ii. Pegfilgrastim
d. Interferons
i. Interferon-Beta
ii. Interferon-Alpha
e. Recombinant Glycosylated Proteins
i. Erythropoietin
ii. Monoclonal Antibodies
1. Adalimumab
2. Bevacizumab
3. Infliximab
4. Rituximab
5. Trastuzumab
6. Other Monoclonal Antibodies
iii. Follitropin
iv. Etanercept
f. Recombinant Peptides
i. Glucagon
ii. Calcitonin

Disease Type (Revenue, USD Million; 2016–2026)
- Oncology
- Blood Disorders
- Chronic Diseases
- Autoimmune Diseases
- Growth Hormone Deficiency
- Infectious Diseases
- Other Diseases

Summary of the report:

The report provides an extensive evaluation of the global Biosimilars market including recent and emerging trends of the industry.
A thorough qualitative and quantitative analysis of the market to offer an accurate insight into the industry to assist the readers and investor capitalize on the current and emerging opportunities of the market.
Extensive analysis of the product portfolio, application spectrum, and end-users to provide in-depth understanding to readers.
Thorough profiling of the leading players in the industry and their expansion strategies.

Browse Complete Report @

Thank you for reading our report. For further information, please connect with us to know more about the customization feature. Our team will work towards providing you a report well suited to your requirements.

Similar Reports –

Non-Small Cell Lung Cancer Market Size, Share & Industry Analysis, By Type, By Product, By Application and Regional Forecast, 2020-2027

Alpha-Adrenoreceptor Antagonists Market Size, Share & Industry Demand, Outlook By Type, By Product, By Application and Regional Forecast, 2020-2027

About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:
John W
Head of Business Development
40 Wall St. 28th floor New York City
NY 10005 United States
Direct Line: +1-212-710-1370